Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Research & Development (2021 - 2025)

Historic Research & Development for Pulse Biosciences (PLSE) over the last 5 years, with Q3 2025 value amounting to $11.4 million.

  • Pulse Biosciences' Research & Development rose 4790.34% to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.5 million, marking a year-over-year increase of 5083.64%. This contributed to the annual value of $32.3 million for FY2024, which is 1632.91% up from last year.
  • Latest data reveals that Pulse Biosciences reported Research & Development of $11.4 million as of Q3 2025, which was up 4790.34% from $12.1 million recorded in Q2 2025.
  • Over the past 5 years, Pulse Biosciences' Research & Development peaked at $12.1 million during Q2 2025, and registered a low of $4.1 million during Q4 2022.
  • Moreover, its 5-year median value for Research & Development was $7.2 million (2024), whereas its average is $7.5 million.
  • Its Research & Development has fluctuated over the past 5 years, first tumbled by 3007.74% in 2022, then skyrocketed by 9045.18% in 2023.
  • Quarter analysis of 5 years shows Pulse Biosciences' Research & Development stood at $5.7 million in 2021, then dropped by 27.62% to $4.1 million in 2022, then surged by 90.45% to $7.8 million in 2023, then soared by 36.71% to $10.7 million in 2024, then rose by 6.86% to $11.4 million in 2025.
  • Its Research & Development stands at $11.4 million for Q3 2025, versus $12.1 million for Q2 2025 and $10.3 million for Q1 2025.